A single shot of gene therapy given to newborn monkeys appears to shield them from HIV, the virus that causes AIDS, for at ...

Georgia continues to face a severe HIV crisis, with 2,442 new diagnoses in 2023—most affecting Black men who have sex with ...

Starting in the mid-2010s, the University of Oxford pediatrician and immunologist began working with scientists in the South African province of KwaZulu-Natal, with the aim of tracking several hundred ...

A single injection at birth could offer years of protection against the virus for vulnerable children in high-risk areas.

With Black women and straight men increasingly at risk, Gilead’s Yeztugo may finally offer a discreet, stigma-free way to ...

Receiving treatment within the first month of life could protect children for at least three years, a study suggests.

Sub-Saharan Africa has taken a cautious but critical step toward greater health self-reliance as locally produced HIV ...

Data from Russia’s defence ministry shows HIV rates among enlisted personnel have skyrocketed since the outbreak of the ...

Gilead Sciences, Inc. has announced that it has received new approval from the U.S. Food and Drug Administration (FDA) for a ...

The Senate Appropriations Committee on Thursday rejected the presidential administration’s proposed termination of the CDC’s ...

The Lagos State Government, through the Lagos State AIDS Control Agency (LSACA), has reaffirmed its leadership and unwavering ...

WHO says the achievement is part of a broader push to bolster local production capacity and improve access to essential ...